Exposure Assessment and PM Source Identification

Klein LW, Stewart JC, Oberdorster G, Frampton MW. Ultrafine particles activate platelets in vitro. American Journal of Respiratory and Critical Care Medicine 2007;175:A169. not available Abstract Shah AP, Stewart JC, Klein LW, Utell MJ, Frampton MW. Effects of carbon ultrafine particles on platelet activation. Proceedings of the American Thoracic Society 2006;3:A551. not availableShah AP, Stewart JC, Klein LW, Utell MJ, Frampton MW. Effects of carbon ultrafine particles on platelet activation. Proceedings of the American Thoracic Society 2006;3:A551. not available Abstract Shah AP, Stewart JC, Pietropaoli AP, Utell MJ, Frampton MW. Vascular effects of carbon ultrafine particle inhalation in diabetics. Proceedings of the American Thoracic Society 2006;3:A387. not availableShah AP, Stewart JC, Pietropaoli AP, Utell MJ, Frampton MW. Vascular effects of carbon ultrafine particle inhalation in diabetics. Proceedings of the American Thoracic Society 2006;3:A387. not available Presentation Frampton M, Stewart J, Chen X, Pietropaoli A, Taubman M, Utell M. Platelet and vascular effects in type 2 diabetics inhaling not available ultrafine carbon particles. Presented at the NIH/EPA Conference, The Role of Air Pollutants in Cardiovascular Disease, Research Triangle Park, NC, October 12-13, 2006. Presentation Stewart JC, Speers D, Frampton MW. Blood leukocyte production of reactive oxygen species in people with type 2 diabetes. Presented at the International Society for Analytical Cytology, Montreal, Canada, May 2006. not available Supplemental